Join
Live feed
·
INSIDERFilingvia Quantisnow
Halozyme Therapeutics Inc. logo

SVP, CHIEF OPERATING OFFICER Caudill Cortney converted options into 9,326 shares and sold $277,905 worth of shares (4,263 units at $65.19), increasing direct ownership by 66% to 12,737 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.) and more on Quantisnow.

SVP, CHIEF OPERATING OFFICER Caudill Cortney converted options into 9,326 shares and sold $277,905 worth of shares (4,263 units at $65.19), increasing direct ownership by 66% to 12,737 units (SEC Form 4) | Quantisnow